New contrast medium accumulates better in MS lesions

The results of this study could help dramatically improve the diagnostic work-up in MS with a potential impact on early treatment. The new contrast medium gadofluorine M supposedly visualizes MS lesions better because it binds especially well to certain components of the extracellular matrix of inflammatory foci. Because of this, it accumulates in these lesions in higher concentrations.

It's only been tested in animals so far, but this is one case where the animal models are probably pretty good. It's interesting we haven't seen more work in the contrast medium area.